Becton Dickinson and Company (BDX)

Return on equity (ROE)

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net income (ttm) US$ in thousands 1,597,000 1,525,000 1,519,000 1,748,000 1,726,000 1,413,000 1,333,000 1,256,000 1,484,000 1,664,000 1,617,000 1,611,000 1,779,000 1,756,000 1,921,000 1,766,000 2,092,000 1,955,000 1,716,000 1,600,000
Total stockholders’ equity US$ in thousands 25,390,000 25,390,000 25,241,000 25,204,000 25,889,000 25,869,000 25,648,000 25,333,000 25,797,000 25,938,000 25,691,000 25,473,000 25,282,000 25,494,000 24,526,000 24,161,000 23,677,000 24,136,000 24,827,000 24,663,000
ROE 6.29% 6.01% 6.02% 6.94% 6.67% 5.46% 5.20% 4.96% 5.75% 6.42% 6.29% 6.32% 7.04% 6.89% 7.83% 7.31% 8.84% 8.10% 6.91% 6.49%

September 30, 2025 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,597,000K ÷ $25,390,000K
= 6.29%


Peer comparison

Sep 30, 2025

Company name
Symbol
ROE
Becton Dickinson and Company
BDX
6.29%
Azenta Inc
AZTA
-6.67%
Embecta Corp
EMBC
Hologic Inc
HOLX
11.68%

See also:

Becton Dickinson and Company Return on Equity (ROE) (Quarterly Data)